Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence: Intervention Development and Feasibility Trial

Trial Profile

Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence: Intervention Development and Feasibility Trial

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 07 Jun 2017

At a glance

  • Drugs Varenicline (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2017 Planned End Date changed from 31 Dec 2017 to 31 Mar 2018.
    • 23 Jan 2017 Planned End Date changed from 1 Mar 2017 to 31 Dec 2017.
    • 17 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top